felin
infecti
periton
fip
fatal
diseas
cat
worldwid
aim
studi
test
two
commerci
avail
reaction
mixtur
revers
transcript
loopmedi
isotherm
amplif
rtlamp
assay
detect
felin
coronaviru
fcov
bodi
caviti
effus
cat
without
fip
order
minim
time
sampl
obtain
result
rna
extract
bodi
caviti
effus
sampl
cat
includ
sampl
cat
definit
diagnosi
fip
sampl
control
cat
similar
clinic
sign
confirm
diseas
two
reaction
mixtur
isotherm
mastermix
optigen
ltdand
molecular
detect
mix
biogal
test
use
primer
design
bind
conserv
region
fcov
membran
protein
gene
assay
conduct
isotherm
condit
use
isotherm
mastermix
optigen
ltd
amplif
time
rang
min
sensit
specif
report
sampl
group
use
molecular
detect
mix
biogal
amplif
time
rang
min
sensit
specif
although
rtlamp
assay
less
sensit
real
time
revers
transcript
pcr
rtpcr
perform
without
need
expens
equip
less
handson
time
modif
primer
might
lead
suitabl
inhous
test
acceler
diagnosi
fip
felin
coronaviru
fcov
member
genu
alphacoronaviru
subfamili
coronavirina
famili
coronavirida
within
order
nidoviral
de
groot
et
al
belong
group
envelop
positivesens
rna
virus
caus
diseas
sever
speci
sever
acut
respiratori
syndrom
sar
human
transmiss
gastroenter
tge
pig
despit
high
preval
fcov
infect
cat
popul
worldwid
fcovinfect
cat
develop
fatal
diseas
felin
infecti
periton
fip
addi
jarrett
chang
virul
harmless
fcov
biotyp
usual
caus
clinic
sign
pathogen
variant
thought
caus
mutat
fcov
spike
protein
gene
chang
et
al
vennema
et
al
mutat
caus
chang
tropism
enterocyt
macrophag
give
fcov
abil
infect
effect
replic
within
cell
macrophag
lineag
caus
lethal
system
diseas
multiorgan
involv
pedersen
median
surviv
time
cat
effus
fip
day
ritz
et
al
diagnosi
fip
commonli
lead
euthanasia
sinc
date
treatment
proven
effect
cat
fip
show
nonspecif
clinic
sign
fever
weight
loss
anorexia
often
accompani
bodi
caviti
effus
andor
ocular
neurolog
sign
definit
diagnosi
fip
ant
mortem
remain
challeng
especi
bodi
caviti
effus
detect
hartmann
et
al
present
gold
standard
diagnosi
fip
consid
immunostain
fcov
antigen
macrophag
within
tissu
lesion
techniqu
requir
invas
tissu
collect
kipar
meli
cat
fip
fcov
detect
rtpcr
cellfre
bodi
caviti
effus
case
serum
blood
sampl
often
neg
doeng
et
al
immunostain
rtpcr
sampl
sent
special
laboratori
result
delay
diagnost
result
lead
unnecessari
test
diseas
withhold
necessari
therapi
treatabl
diseas
delay
euthanasia
cat
suffer
sever
sign
fip
therefor
fast
simpl
point
care
test
would
benefici
diagnost
process
loopmedi
isotherm
amplif
lamp
simpl
rapid
costeffect
nucleic
acid
amplif
method
notomi
et
al
alreadi
use
detect
coronavirus
human
sever
anim
speci
hong
et
al
nemoto
et
al
set
four
six
primer
use
form
product
selfhybrid
loop
structur
use
dna
polymeras
strand
displac
activ
melt
anneal
step
requir
amplif
product
differ
length
form
constant
temperatur
nagamin
et
al
sinc
lamp
reaction
requir
simpl
heat
block
constant
temperatur
dna
amplif
detect
fluoresc
color
chang
method
appli
pointofcar
diagnost
surabattula
et
al
aim
studi
test
specif
sensit
two
commerci
avail
reaction
mixtur
revers
transcript
lamp
rtlamp
detect
fcov
bodi
caviti
effus
cat
without
fip
minim
time
sampl
obtain
result
studi
includ
cat
present
clinic
small
anim
intern
medicin
lmu
munich
germani
cat
includ
bodi
caviti
effus
everi
cat
present
bodi
caviti
effus
fip
potenti
differenti
diagnosi
earlier
studi
show
fip
respons
effus
remain
case
caus
malignoma
cardiac
insuffici
purul
seros
hirschberg
et
al
fip
group
n
includ
cat
definit
diagnosi
fip
one
method
effus
cat
fip
test
posit
fcov
rtpcr
commerci
laboratori
sampl
put
diseasecaus
mutat
could
detect
rtpcr
detect
method
describ
previous
felten
et
al
cat
fip
diagnosi
achiev
postmortem
examin
includ
full
bodi
necropsi
histopatholog
examin
diagnosi
fip
confirm
typic
histolog
lesion
detect
surfacebound
multisystem
pyogranulomat
fibrinonecrot
diseas
venul
without
highprotein
exud
cat
full
bodi
necropsi
immunohistolog
stain
fcovantibodi
done
tissu
section
return
posit
result
immunofluoresc
stain
fcov
antigen
macrophag
thorac
abdomin
effus
done
cat
sampl
return
posit
result
summari
case
fip
group
found
supplementari
tabl
cat
includ
control
group
n
definit
diagnos
diseas
fip
explain
effus
cat
control
group
suffer
neoplasia
n
decompens
cardiac
diseas
n
inflammatori
diseas
n
bacteri
periton
pleurisi
diseas
n
one
cat
chronic
thorac
chylou
effus
unknown
origin
secondari
fibroplast
pleurisi
anoth
cat
end
stage
kidney
diseas
caus
effus
one
cat
thorac
effus
subcutan
urethr
bypass
placement
resolv
treatment
diseas
cat
control
group
n
definit
confirm
antemortem
n
necropsi
histopatholog
examin
n
antemortem
diagnosi
establish
echocardiographi
cardiac
diseas
n
cytolog
neoplasia
n
immunofluoresc
stain
fcov
antigen
macrophag
thorac
abdomin
effus
done
cat
three
posit
eight
neg
result
effus
cat
control
group
test
fcov
rtpcr
result
neg
rtpcr
detect
method
describ
previous
felten
et
al
summari
case
control
group
found
supplementari
tabl
bodi
caviti
effus
sampl
cat
obtain
ant
mortem
ultrasound
guidanc
diagnost
purpos
use
sampl
studi
approv
institut
anim
care
use
committe
ethikkommiss
de
zentrum
klinisch
tiermedizin
permiss
number
sampl
store
ml
eppendorf
safelock
microcentrifug
tube
assay
sampl
centrifug
g
supernat
centrifug
thorac
abdomin
fluid
use
rna
extract
use
fresh
fluid
sampl
omiss
centrifug
step
consid
includ
intact
cell
high
viral
burden
pedersen
et
al
thaw
sampl
cell
integr
lost
cell
debri
remov
viral
rna
isol
use
commerci
zr
viral
rna
zymo
research
corp
follow
manufactur
instruct
briefli
aliquot
sampl
mix
buffer
facilit
viral
particl
lysi
allow
rna
adsorpt
onto
matrix
column
rna
wash
elut
rnase
free
water
extract
rna
aliquot
store
eppendorf
ml
safelock
microcentrifug
tube
process
rtlamp
primer
design
assist
softwar
primerexplor
http
primerexplorerjp
base
sequenc
analysi
gene
membran
protein
select
target
highli
conserv
among
fcov
strain
dna
sequenc
posit
fcov
strain
black
genbank
access
number
use
design
rtlamp
primer
use
studi
set
six
primer
includ
two
outer
primer
forward
primer
backward
primer
two
inner
primer
forward
inner
primer
fip
backward
inner
primer
bip
two
loop
primer
forward
loop
primer
loopf
backward
loop
primer
loopb
select
target
sequenc
fig
tabl
detect
fcov
perform
use
rtlamp
two
differ
commerci
reaction
mixtur
isotherm
mastermix
optigen
ltd
uk
molecular
detect
mix
biogal
israel
compar
use
set
primer
amplif
follow
isotherm
mastermix
protocol
total
volum
per
reaction
tube
includ
isotherm
master
mix
templat
primer
mix
iii
revers
transcriptas
thermo
scientif
primer
mix
consist
pmol
primer
pmol
fip
bip
primer
pmol
loopf
loopb
primer
neg
control
water
ad
instead
templat
reaction
mix
incub
min
realtim
pcr
system
appli
biosystem
rtlamp
fluoresc
dna
product
measur
everi
minut
fam
detect
channel
max
nm
time
threshold
cross
analyz
posit
sampl
posit
rtpcr
sequenc
mutat
includ
everi
run
sampl
run
realtim
pcr
system
subject
melt
curv
analysi
run
singl
sharp
peak
melt
curv
analysi
demonstr
amplif
singl
pcr
product
posit
sampl
show
singl
peak
melt
temperatur
posit
control
sampl
follow
molecular
detect
protocol
reaction
mix
contain
luminesc
reagent
templat
primer
mix
addit
superscript
iii
revers
transcriptas
thermo
scientif
primer
mix
consist
pmol
primer
pmol
fip
bip
primer
pmol
loopf
loopb
primer
neg
control
water
ad
instead
templat
reaction
mix
incub
min
reader
biogal
amplif
detect
measur
bioluminesc
twice
everi
minut
fig
pcr
product
method
verifi
agaros
gel
show
typic
pattern
multipl
band
differ
molecular
weight
fig
result
sampl
fcov
rtlamp
assay
use
two
differ
commerci
reaction
mixtur
shown
tabl
two
sampl
test
fals
posit
use
isotherm
mastermix
one
sampl
test
fals
posit
molecular
detect
mix
sensit
specif
report
sampl
group
rtlamp
assay
shown
tabl
molecular
detect
mix
perform
better
sensit
specif
isotherm
mastermix
amplif
time
isotherm
mastermix
posit
rang
min
molecular
detect
mix
posit
min
present
studi
rtlamp
assay
evalu
diagnost
tool
detect
fcov
order
distinguish
cat
without
fip
present
bodi
caviti
effus
time
sampl
result
kept
minimum
isol
rna
min
use
simpl
rna
extract
kit
commerci
avail
reaction
mixtur
allow
easi
fast
prepar
amplif
reaction
lamp
assay
direct
detect
method
built
amplif
devic
prefer
sinc
open
lamp
reaction
tube
amplif
advis
decreas
risk
carryov
contamin
parida
et
al
zanoli
spoto
present
studi
portabl
devic
result
use
molecular
detect
mix
posit
neg
amplif
reaction
indic
devic
make
compat
pointofcar
instrument
isotherm
mastermix
intend
use
portabl
devic
part
studi
machin
use
instead
replic
reaction
condit
constant
block
temperatur
use
compar
fluoresc
detect
system
assay
test
similar
demand
concern
handl
skill
prepar
time
detect
posit
sampl
took
half
time
isotherm
mastermix
compar
molecular
detect
mix
yet
test
requir
less
min
specif
method
report
sampl
group
compar
respect
howev
fals
posit
result
test
diagnos
fatal
diseas
critic
occur
crossreact
lampprim
carryov
contamin
might
caus
fals
posit
result
howev
neg
control
without
sampl
materi
show
indic
carryov
contamin
stay
neg
lamp
assay
anoth
possibl
fals
posit
result
detect
fcov
cat
without
fip
sinc
system
spread
fcov
occur
inadvert
result
fip
porter
et
al
explan
like
three
sampl
cat
without
fip
posit
rtlamp
sinc
three
neg
rtpcr
sensit
molecular
detect
mix
superior
report
sampl
group
compar
isotherm
mastermix
use
primer
pcr
condit
sinc
sampl
rtpcr
rtlamp
preanalyt
treatment
frozen
thaw
centrifug
result
directli
compar
show
rtpcr
fcov
perform
much
better
rtlamp
sampl
group
agreement
studi
coronavirus
rtlamp
also
exhibit
lower
analyt
sensit
compar
rtpcr
bhadra
et
al
fals
neg
result
occur
sampl
lower
viral
burden
fcov
viral
load
determin
rtpcr
effus
found
quit
low
sampl
fipsuspect
cat
lorusso
et
al
studi
result
rtpcr
return
posit
neg
without
quantif
leav
open
question
whether
effus
high
viral
load
result
posit
rtlamp
detect
anoth
possibl
reason
lack
sensit
might
sequenc
current
fcov
strain
show
sequenc
variat
compar
sequenc
deposit
genbank
databas
use
design
rtlamp
primer
although
primer
chosen
bind
highli
conserv
region
variat
occur
might
impair
bind
eventu
lead
low
amplif
result
poor
sensit
reliabl
primer
rtpcr
target
utr
fcov
sequenc
rtlamp
primer
suggest
primerexplor
softwar
region
includ
sequenc
differ
region
select
modif
primer
might
enhanc
bind
improv
sensit
two
studi
lampbas
identif
fcov
publish
date
studi
thailand
test
sampl
bodi
caviti
effus
cat
suspect
fip
rtpcr
rtlamp
sampl
test
posit
rtlamp
rtpcr
vs
techangamsuwan
et
al
howev
inclus
criteria
cat
suspect
fip
describ
studi
control
sampl
consist
plasma
fecal
sampl
healthi
cat
without
contact
cat
sampl
healthi
control
group
also
posit
result
rtlamp
rtpcr
vs
author
mention
high
rate
fals
posit
neg
control
templat
control
use
rtlamp
remain
unclear
whether
rtpcr
less
sensit
rtlamp
prone
unspecif
amplif
second
studi
differ
sampl
type
cat
clinic
suspicion
fip
fecal
sampl
screen
fcovshed
cat
test
stranieri
et
al
sampl
type
includ
effus
rtpcr
twice
mani
posit
result
rtlamp
none
rtpcrneg
sampl
posit
rtlamp
method
agreement
find
sensit
rtlamp
appear
inferior
rtpcr
detect
amplif
studi
use
gel
electrophoresi
one
studi
stranieri
et
al
addit
use
detect
color
chang
violet
blue
hydroxynaphtol
blue
gel
electrophoresi
quit
timeconsum
color
chang
difficult
detect
sampl
low
amplif
amplif
detect
fluoresc
luminesc
use
present
studi
prefer
sinc
result
read
immedi
could
easili
convert
quantit
format
standard
curv
perspect
futur
rtlamp
reaction
viru
detect
could
run
new
devic
integr
nucleic
acid
extract
amplif
detect
miniatur
format
achiev
true
pointofcar
diagnosi
stumpf
et
al
conclus
rtlamp
present
studi
rel
specif
sensit
sampl
type
restrict
effus
cat
unequivoc
diagnos
fip
cat
without
fip
clinic
sign
indic
fip
realist
set
veterinarian
would
use
test
detect
fcov
effus
sampl
rtlamp
assay
molecular
detect
mix
use
clinic
set
certain
extent
howev
replac
convent
rtpcr
method
sensit
specif
enhanc
optim
primer
amplif
condit
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
molecular
detect
mix
reader
provid
biogal
free
charg
biogal
involv
studi
design
collect
analysi
interpret
data
write
report
decis
submit
articl
public
fcov
rtpcr
subsequ
mutat
detect
done
idexx
free
charg
idexx
involv
studi
design
collect
analysi
interpret
data
write
report
decis
submit
articl
public
